(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MINT RX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MINT RX

ST13

US500000088003252

Class

5, 44

Filing

88003252

Registration

5679059

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

10/29/2025

Trademark type

Combined

Nice classes

5, 44

Filing date

06/16/2018

Registration date

02/19/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/28/2025

Last transaction

10/29/2025

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

01/01/2018

First use in commerce

01/01/2018

Drawing code

3

Owner type

16

Owner location

SCOTTSDALE, AZ

Examiner

POLLACK,ALISON FRIEDBERG

Current location

Historical data usage

Mark description

The mark consists of the stylized letters "M I N T" and then a stylized "R" integrated with a stylized "x" forming "RX", below a teardrop shape design with an upside down ribbon positioned inside of the teardrop.

Holders and representatives

Holders

SEDONA PHARMACY GROUP, LLC
PHARMAMEDRX, LLC
Trulee Health, LLC

Representatives

Yan Song AEON Law, PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology

Class 44

Preparation of prescriptions by pharmacists; Providing health care information by telephone and the internet

Publications

History of USPTO decisions and trademark events.

31 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/23/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/23/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/23/2025

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

09/16/2025

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

08/28/2025

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

08/28/2025

C.7C

NEW CERTIFICATE UNDER SECTION 7 - PROCESSED

08/28/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/25/2025

ES8R

TEAS SECTION 8 RECEIVED

08/15/2025

ES7R

TEAS SECTION 7 REQUEST RECEIVED

04/11/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/08/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/19/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/19/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/04/2018

PUBO

PUBLISHED FOR OPPOSITION

12/04/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/14/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/01/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/01/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/30/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/30/2018

ALIE

ASSIGNED TO LIE

10/30/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/24/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/18/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/18/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/04/2018

GNRT

NON-FINAL ACTION E-MAILED

10/04/2018

CNRT

NON-FINAL ACTION WRITTEN

10/04/2018

DOCK

ASSIGNED TO EXAMINER

10/03/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/22/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/21/2018

NWAP

NEW APPLICATION ENTERED

06/20/2018

Continuous trademark protection

Get notified about every new filing that threatens MINT RX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.